TickerFacts.

Foxo Technologies Inc. (FOXO): Shareholders' Equity

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$11.14M
As of 2025-12-31
$988.3K
As of 2026-06-30
+18.4%
3-year compound annual growth
2020-12-31: -$16.19M2021-12-31: -$25.22M2022-12-31: $6.71M2023-12-31: -$14.10M2024-12-31: $5.32M2025-12-31: $11.14M$11.14M
2020-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$11.14M+109.3%2026-04-15, Balance as of period end
2024-12-31$5.32Mn/m2026-04-15, Balance as of period end
2023-12-31-$14.10Mn/m2025-04-15, Balance as of period end
2022-12-31$6.71Mn/m2024-06-06, Balance as of period end
2021-12-31-$25.22Mn/c2023-03-31, Balance as of period end
2020-12-31-$16.19Mn/a2022-03-07, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Foxo Technologies Inc. (FOXO)2025-12-31$11.14M+109.3%
OmniAb, Inc. (OABI)2025-12-31$267.03M-7.2%
MaxCyte, Inc. (MXCT)2025-12-31$171.49M-16.9%
bioAffinity Technologies, Inc. (BIAF)2025-12-31$7.28M+179.7%
Absci Corp (ABSI)2025-12-31$189.45M+5.8%
NRC Health (NRC)2025-12-31$13.99M-55.3%
iSpecimen Inc. (ISPC)2025-12-31$3.09M-6.7%
OneMedNet Corp (ONMD)2025-12-31-$2.96Mn/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31-$1.16Mn/m

Compare FOXO, OABI, MXCT, BIAF side by side · Screen every company in Services-Commercial Physical & Biological Research ↗